dc.contributor.author | Wong, HH | en_US |
dc.contributor.author | Lemoine, NR | en_US |
dc.contributor.author | Wang, YH | en_US |
dc.date.accessioned | 2017-08-25T11:28:38Z | |
dc.date.issued | 2010-01 | en_US |
dc.date.submitted | 2017-07-05T01:18:34.623Z | |
dc.identifier.issn | 1999-4915 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/25475 | |
dc.format.extent | 78 - 106 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | VIRUSES-BASEL | en_US |
dc.rights | CC-BY | |
dc.subject | oncolytic virus | en_US |
dc.subject | adenovirus | en_US |
dc.subject | vaccinia virus | en_US |
dc.subject | cancer gene | en_US |
dc.subject | host immune response | en_US |
dc.subject | HERPES-SIMPLEX-VIRUS | en_US |
dc.subject | TUMOR-NECROSIS-FACTOR | en_US |
dc.subject | REPLICATION-SELECTIVE ADENOVIRUS | en_US |
dc.subject | VESICULAR STOMATITIS-VIRUS | en_US |
dc.subject | NEWCASTLE-DISEASE VIRUS | en_US |
dc.subject | TELOMERASE-SPECIFIC VIROTHERAPY | en_US |
dc.subject | COMPLEMENT REGULATORY PROTEINS | en_US |
dc.subject | DELETION MUTANT ADENOVIRUS | en_US |
dc.subject | POTENT ANTITUMOR IMMUNITY | en_US |
dc.subject | SQUAMOUS-CELL CARCINOMA | en_US |
dc.title | Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles | en_US |
dc.type | Article | |
dc.rights.holder | © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. | |
dc.identifier.doi | 10.3390/v2010078 | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 2 | en_US |